Evidence map›Paper›PMID 24371481›Full record

ReviewMaedica2013

Neurotoxicity of immunosuppressive therapies in organ transplantation.

Daniela Anghel, Radu Tanasescu, Ana Campeanu, Ioana Lupescu, Giulio Podda, Ovidiu Bajenaru

Abstract readReview
In one paragraph

Review in Maedica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. World journal of hepatology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Clinical Impact and Risk Factors of Seizure After Liver Transplantation: A Nested Case-Control Study.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  14. Review of two immunosuppressants: tacrolimus and cyclosporine.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniela Anghel"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Fundeni Clinical Institute, Department of Neurology, Bucharest, Romania.
Radu Tanasescu"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Fundeni Clinical Institute, Department of Neurology, Bucharest, Romania ; University of Nottingham, Academic Division of Clinical Neurology, Nottingham, UK.
Ana CampeanuColentina Clinical Hospital, Department of Neurology, Bucharest, Romania.
Ioana Lupescu"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Fundeni Clinical Institute, Department of Radiology, Medical Imaging and Nuclear Medicine, Bucharest, Romania.
Giulio PoddaUniversity of Nottingham, Academic Division of Clinical Neurology, Nottingham, UK.
Ovidiu Bajenaru"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Emergency University Hospital, Department of Neurology, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractImmunosuppressive agents have revolutionized clinical transplantation medicine, allowing the avoidance of immune system attack on the transplanted graft. Nevertheless, the use of medications such as cyclosporine, tacrolimus and others also brought the side effects of these drugs. Early identification of drug-induced neurotoxicity in transplanted patients and of its specific causes is important, not only because of patient's poor clinical status but because of concomitant systemic and metabolic disorders which may obscure symptoms. Treatment and prognosis are highly dependent on the type of complication and it's early recognition. This review focuses on the clinical entities of neurotoxicity caused by immunosuppressive drugs in transplanted patients.

Indexed as

immunosuppressive drugsneurotoxicityposttransplant states

Identifiers

PMID24371481
PMCPMC3865126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.